Dry Eye Products Market Scope And Analysis

Dry Eye Products Market Report Scope

Competitive Landscape and Key Companies:

The dry eye products market forecast can help stakeholders in this marketplace plan their growth strategies. Santen Pharmaceutical Co Ltd, Johnson & Johnson, OASIS Medical, URSAPHARM Arzneimittel GmbH, Rohto Pharmaceutical Co Ltd, OCuSOFT Inc, Bausch Health Companies Inc, AbbVie Inc, Prestige Consumer Healthcare Inc, Farmigea SpA, and Alcon AG are among the prominent companies profiled in the dry eye products market report. These companies focus on developing new technologies, upgrading existing products, and expanding their geographic presence to meet the growing consumer demand worldwide. As per company press releases, the following are a few recent developments by major companies in the market:

• In September 2023, Bausch + Lomb Corporation (Bausch + Lomb), a subsidiary of Bausch Health Companies Inc, completed its acquisition of XIIDRA (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease. The product specifically focuses on inflammation associated with dry eye and certain other ophthalmology assets.
• In November 2022, Santen Pharmaceutical Co Ltd launched DIQUAS LX Ophthalmic Solution 3% (diquafosol sodium) in Japan. The DIQUAS LX solution is a formulation that requires the administration of one drop three times daily to treat dry eye disease.
• In August 2022, Alcon and Aerie Pharmaceuticals Inc. entered into a definitive merger agreement. As a part of this deal, Alcon acquired Aerie. This transaction helps bolster Alcon’s presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.
• In July 2021, TheraTears was acquired by Prestige Consumer Healthcare Inc. The acquisition of TheraTears added to Prestige's leading eye care portfolio and provided the company with new long-term growth prospects.
• In February 2021, Allergan launched Refresh Digital, a new lubricant eye drop designed to specifically relieve dryness and irritation caused by prolonged screen time.
• In June 2020, OCuSOFT Inc. and EKKDA Research LLC entered into a sales-distribution agreement. This partnership helps the partners to establish and develop in the ophthalmology and optometry-related business. EKKDA’s research LLC's projects are focused fundamentally on eye care.
• In May 2020, AbbVie Inc acquired Allergan plc as a part of the company's inorganic business strategy. The acquisition has provided the company access to and expanded its business portfolio in the eye care associated markets.
• In January 2020, Santen Pharmaceutical Co Ltd as a part of its business expansion in China constructed its second plant for its Chinese subsidiary "Santen Pharmaceutical (China) Co Ltd." to support the growing demand for products in China.